Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2025-12-25 @ 2:17 AM
NCT ID: NCT02874560
Eligibility Criteria: Inclusion Criteria: * Patients must be male or female adult patients aged 18 to 37 years with a diagnosis of schizophrenia according to diagnostic and statistical manual of mental disorders (DSM-IV) criteria * Treated for schizophrenia * Having read understood and signed an informed consent (for patients under legal guardianship, the legal guardian will be informed by the physician) * Patients must have initiated a long-acting injectable antipsychotic treatment less than 2 months after a previous treatment * Patients must have been under monitoring by a treatment team from a hospital, a medical psychiatric centre or a clinic for at least 6 months and must be likely to be followed by the same team for the next year Exclusion Criteria: * Resistant schizophrenia (no response after receiving two successive antipsychotic treatments at an effective dose, each over at least a four-week period) * Drug or alcohol dependence or abuse (other than nicotine or caffeine abuse) diagnosed according to DSM-IV in the month preceding the study inclusion process which according to the investigator could compromise the participation in the study * History of neuroleptic malignant syndrome * Inability to comply with the requirements of the study (e.g., intellectual deficiency, inability or unwillingness to answer questionnaires) according to the investigator's opinion * Patients under trusteeship or patient receiving psychiatric care without his consent (except patient under care program) * Participation in another study within 30 days prior to the study inclusion period
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 37 Years
Study: NCT02874560
Study Brief:
Protocol Section: NCT02874560